Your browser doesn't support javascript.
loading
Guillain-Barré syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity.
Al-Hakem, Helle; Sindrup, Søren H; Andersen, Henning; de la Cour, Charlotte Dornonville; Lassen, Lisbeth L; van den Berg, Bianca; Jacobs, Bart C; Harbo, Thomas.
Afiliación
  • Al-Hakem H; Department of Neurology, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus, Denmark. helsma@rm.dk.
  • Sindrup SH; Department of Neurology, Odense University Hospital, Odense, Denmark.
  • Andersen H; Department of Neurology, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus, Denmark.
  • de la Cour CD; Department of Clinical Neurophysiology, Rigshospitalet, Copenhagen, Denmark.
  • Lassen LL; Department of Neurology, Rigshospitalet Glostrup, Copenhagen, Denmark.
  • van den Berg B; Department of Neurology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Jacobs BC; Department of Neurology and Immunology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Harbo T; Department of Neurology, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus, Denmark.
J Neurol ; 266(2): 440-449, 2019 Feb.
Article en En | MEDLINE | ID: mdl-30536111
OBJECTIVES: To describe the epidemiology and clinical heterogeneity of Guillain-Barré syndrome (GBS) in Denmark and to compare a population-based cohort to prospectively included patients in the International GBS Outcome Study (IGOS). METHODS: The incidence rate (IR) of GBS in Denmark from September 2012 to December 2015, applying the National Institute of Neurological Disorders and Stroke (NINDS) diagnostic criteria, was estimated and the level of diagnostic certainty was described with the Brighton criteria. All cases registered with a diagnosis of GBS or other inflammatory neuropathies in the Danish National Hospital Registry were reviewed for diagnostic criteria and for information on treatment and clinical course. RESULTS: A total of 299 GBS cases were confirmed, corresponding to a crude IR of 1.59 (95% CI 1.42-1.78) per 100,000 per year. The Brighton criteria level 1-3 of diagnostic certainty was met in 279 (93%) of the patients. Thirty-five percent of the patients were mildly affected (GBS disability score < 3) and a correlation between high age and high disability score at nadir was found (Spearman's rank correlation coefficient 0.42, p < 0.0001). The group of 89 (30%) patients who were enrolled in IGOS had higher GBS disability score at nadir, were admitted 5 days earlier, reached nadir 4 days faster, and a larger proportion received treatment with IVIg (all p < 0.05). CONCLUSION: The epidemiology and full clinical spectrum of GBS are described in a population-based study. This includes a larger proportion of milder cases that are underrepresented in prospective cohorts such as IGOS.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Síndrome de Guillain-Barré Tipo de estudio: Diagnostic_studies / Incidence_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Neurol Año: 2019 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Síndrome de Guillain-Barré Tipo de estudio: Diagnostic_studies / Incidence_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Neurol Año: 2019 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Alemania